• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤浸润淋巴细胞的免疫效应及其与卵巢恶性肿瘤患者生存率的关系。

Immune effect of tumor-infiltrating lymphocytes and its relation to the survival rate of patients with ovarian malignancies.

作者信息

Ma D, Gu M J

机构信息

Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical University, Wuhan.

出版信息

J Tongji Med Univ. 1991;11(4):235-9. doi: 10.1007/BF02888158.

DOI:10.1007/BF02888158
PMID:1668016
Abstract

Tumor-infiltrating lymphocytes (TIL) in histological sections from 94 patients with ovarian malignancies were quantitated for their relation to the prognosis of the patients. It was found that the degree of lymphocyte infiltration directly affected the patients' survival rate and also related to clinical staging of the patients, as well as grading and histologic typing of the tumor. T lymphocytes characterized by alpha-naphthyl acetate (ANAE) staining were the major cells in the stroma of ovarian malignancies. Ultrastructural study of TIL and cancer cells suggested that tumor cell degeneration is related to the effect of TIL.

摘要

对94例卵巢恶性肿瘤患者组织切片中的肿瘤浸润淋巴细胞(TIL)进行定量分析,以研究其与患者预后的关系。发现淋巴细胞浸润程度直接影响患者生存率,且与患者的临床分期、肿瘤分级及组织学类型有关。以α-萘乙酸酯(ANAE)染色为特征的T淋巴细胞是卵巢恶性肿瘤间质中的主要细胞。TIL与癌细胞的超微结构研究表明,肿瘤细胞退变与TIL的作用有关。

相似文献

1
Immune effect of tumor-infiltrating lymphocytes and its relation to the survival rate of patients with ovarian malignancies.肿瘤浸润淋巴细胞的免疫效应及其与卵巢恶性肿瘤患者生存率的关系。
J Tongji Med Univ. 1991;11(4):235-9. doi: 10.1007/BF02888158.
2
Treatment Regimen, Surgical Outcome, and T-cell Differentiation Influence Prognostic Benefit of Tumor-Infiltrating Lymphocytes in High-Grade Serous Ovarian Cancer.治疗方案、手术结果和 T 细胞分化影响高等级浆液性卵巢癌中肿瘤浸润淋巴细胞的预后获益。
Clin Cancer Res. 2016 Feb 1;22(3):714-24. doi: 10.1158/1078-0432.CCR-15-1617. Epub 2015 Sep 18.
3
Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma.CD3+肿瘤浸润淋巴细胞在卵巢癌中的预后意义。
Gynecol Oncol. 2008 Feb;108(2):415-20. doi: 10.1016/j.ygyno.2007.10.016. Epub 2007 Nov 26.
4
Patient inflammatory status and CD4+/CD8+ intraepithelial tumor lymphocyte infiltration are predictors of outcomes in high-grade serous ovarian cancer.患者炎症状态和 CD4+/CD8+上皮内肿瘤淋巴细胞浸润是高级别浆液性卵巢癌结局的预测因素。
Gynecol Oncol. 2018 Oct;151(1):10-17. doi: 10.1016/j.ygyno.2018.07.025. Epub 2018 Aug 2.
5
PD-1 and CD103 Are Widely Coexpressed on Prognostically Favorable Intraepithelial CD8 T Cells in Human Ovarian Cancer.PD-1 和 CD103 在人卵巢癌中具有预后意义的上皮内 CD8 T 细胞上广泛共表达。
Cancer Immunol Res. 2015 Aug;3(8):926-35. doi: 10.1158/2326-6066.CIR-14-0239. Epub 2015 May 8.
6
Tumor-infiltrating lymphocytes expressing the tissue resident memory marker CD103 are associated with increased survival in high-grade serous ovarian cancer.表达组织驻留记忆标志物 CD103 的肿瘤浸润淋巴细胞与高级别浆液性卵巢癌患者生存率的提高相关。
Clin Cancer Res. 2014 Jan 15;20(2):434-44. doi: 10.1158/1078-0432.CCR-13-1877. Epub 2013 Nov 4.
7
PD-L1 expression is associated with tumor-infiltrating T cells and favorable prognosis in high-grade serous ovarian cancer.程序性死亡配体1(PD-L1)表达与高级别浆液性卵巢癌中的肿瘤浸润性T细胞及良好预后相关。
Gynecol Oncol. 2016 May;141(2):293-302. doi: 10.1016/j.ygyno.2016.03.008. Epub 2016 Mar 16.
8
Immunosensitization of resistant human tumor cells to cytotoxicity by tumor infiltrating lymphocytes.肿瘤浸润淋巴细胞使耐药性人类肿瘤细胞对细胞毒性产生免疫致敏作用。
Int J Oncol. 2003 Feb;22(2):431-7.
9
CD20+ tumor-infiltrating lymphocytes have an atypical CD27- memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancer.CD20+ 肿瘤浸润淋巴细胞具有非典型的 CD27- 记忆表型,与 CD8+ T 细胞一起促进卵巢癌的预后良好。
Clin Cancer Res. 2012 Jun 15;18(12):3281-92. doi: 10.1158/1078-0432.CCR-12-0234. Epub 2012 May 2.
10
Large-scale expansion in interleukin-2 of tumor-infiltrating lymphocytes from patients with ovarian carcinoma for adoptive immunotherapy.对卵巢癌患者的肿瘤浸润淋巴细胞进行白细胞介素-2大规模扩增以用于过继性免疫治疗。
J Immunol Methods. 1994 Jan 3;167(1-2):145-60. doi: 10.1016/0022-1759(94)90084-1.

引用本文的文献

1
Regulatory T Cells with Additional COX-2 Expression Are Independent Negative Prognosticators for Vulvar Cancer Patients.COX-2 表达增加的调节性 T 细胞是外阴癌患者独立的预后不良因素。
Int J Mol Sci. 2022 Apr 22;23(9):4662. doi: 10.3390/ijms23094662.
2
Immunology and Immune Checkpoint Inhibition in Ovarian Cancer - Current Aspects.卵巢癌中的免疫学与免疫检查点抑制——当前进展
Geburtshilfe Frauenheilkd. 2021 Oct;81(10):1128-1144. doi: 10.1055/a-1475-4335. Epub 2021 Jul 6.
3
Preclinical and Clinical Immunotherapeutic Strategies in Epithelial Ovarian Cancer.

本文引用的文献

1
Histologic correlates of virulence in ovarian adenocarcinoma. II. Morphologic correlates of host response.卵巢腺癌毒力的组织学关联。II. 宿主反应的形态学关联。
Am J Obstet Gynecol. 1982 Dec 15;144(8):885-9. doi: 10.1016/0002-9378(82)90178-8.
2
Prognostic factors in malignant epithelial ovarian tumors.恶性上皮性卵巢肿瘤的预后因素
Gynecol Oncol. 1983 Jun;15(3):370-80. doi: 10.1016/0090-8258(83)90055-0.
3
Rapid method for determining T lymphocyte levels using acid alpha-naphthyl acetate esterase.用酸性α-萘乙酸酯酶测定T淋巴细胞水平的快速方法。
上皮性卵巢癌的临床前和临床免疫治疗策略
Cancers (Basel). 2020 Jul 2;12(7):1761. doi: 10.3390/cancers12071761.
4
Potential clinical application of tumor-infiltrating lymphocyte therapy for ovarian epithelial cancer prior or post-resistance to chemotherapy.肿瘤浸润淋巴细胞治疗在卵巢上皮性癌化疗耐药前后的潜在临床应用。
Cancer Immunol Immunother. 2019 Nov;68(11):1747-1757. doi: 10.1007/s00262-019-02402-z. Epub 2019 Oct 10.
5
Role of tumor microenvironment in ovarian cancer pathobiology.肿瘤微环境在卵巢癌病理生物学中的作用。
Oncotarget. 2018 Apr 27;9(32):22832-22849. doi: 10.18632/oncotarget.25126.
6
The prognostic value of tumor-infiltrating T lymphocytes in ovarian cancer.肿瘤浸润性T淋巴细胞在卵巢癌中的预后价值。
Oncotarget. 2017 Feb 28;8(9):15621-15631. doi: 10.18632/oncotarget.14919.
7
Tumor infiltrating lymphocytes in ovarian cancer.卵巢癌中的肿瘤浸润淋巴细胞
Cancer Biol Ther. 2015;16(6):807-20. doi: 10.1080/15384047.2015.1040960. Epub 2015 Apr 20.
8
Enumeration of leukocyte infiltration in solid tumors by confocal laser scanning microscopy.通过共聚焦激光扫描显微镜对实体瘤中白细胞浸润进行计数。
BMC Immunol. 2006 Jul 21;7:16. doi: 10.1186/1471-2172-7-16.
9
Expression of EBAG9/RCAS1 is associated with advanced disease in human epithelial ovarian cancer.EBAG9/RCAS1的表达与人类上皮性卵巢癌的晚期疾病相关。
Br J Cancer. 2004 Jun 1;90(11):2197-202. doi: 10.1038/sj.bjc.6601832.
Stain Technol. 1981 May;56(3):189-93. doi: 10.3109/10520298109067309.
4
Lymphocytic infiltration and survival in rectal cancer.直肠癌中的淋巴细胞浸润与生存情况
J Clin Pathol. 1986 Jun;39(6):585-9. doi: 10.1136/jcp.39.6.585.
5
In vivo antitumor activity of tumor-infiltrating lymphocytes expanded in recombinant interleukin-2.重组白细胞介素-2扩增的肿瘤浸润淋巴细胞的体内抗肿瘤活性
J Natl Cancer Inst. 1987 Nov;79(5):1067-75.
6
Tumor biology.肿瘤生物学
Am J Clin Oncol. 1988 Jun;11(3):253-74. doi: 10.1097/00000421-198806000-00004.
7
A correlation between the expression of CD 8 antigen and specific cytotoxicity of tumor-infiltrating lymphocytes.CD8抗原表达与肿瘤浸润淋巴细胞特异性细胞毒性之间的相关性。
Jpn J Cancer Res. 1989 Mar;80(3):249-56. doi: 10.1111/j.1349-7006.1989.tb02301.x.